Comparison

PLA2G4A, Recombinant, Human (Cytosolic Phospholipase A2, cPLA2, Phospholipase A2 Group IVA, Phospholipase A2, Phosphatidylcholine 2-acylhydrolase, Lysophospholipase, PLA2G4, CPLA2)

Item no. USB-P4074-03R
Manufacturer United States Biological
Amount 10 ug
Category
Type Enzymes
Format Liquid
Specific against other
Purity ≥80% by SDS-PAGE under reducing conditions and visualized by silver stain and quantitative densitometry by Coomassie Blue stain Endotoxin: ≤1EU/ug (LAL)
ECLASS 10.1 32160410
ECLASS 11.0 32160410
UNSPSC 12352204
Shipping Condition Cool pack
Available
Manufacturer - Category
Molecular Biology / MB-Enzymes, Phospholipase
Shipping Temperature
Blue Ice
Storage Conditions
-20°C
Molecular Weight
86
Grade
Purified
Form
Supplied as a liquid in 25mM Tris, 500mM sodium chloride, pH 7.5, 1mM TCEP, 0.02% Brij-35, 20% glycerol.
EU Commodity Code
30021019
Description
Cytosolic Phospholipase A2a (PLA2G4A) belongs to the group IV phospholipase A2 family. These enzymes hydrolyze the ester bond at the second position (sn-2) of membrane glycerophospholipids. The group IV phospholipase A2 (PLA2G4) family is comprised of six intracellular enzymes. PLA2G4A has a preference for arachidonic acid in the sn-2 position of phospholipids indicating its involvement in the metabolism of eicosanoids. Its active site is characterized by a serine and aspartic acid dyad. The overall structural feature displays two domains, a lipid binding C2 domain and a catalytic a/b hydrolase domain. PLA2G4A translocation to the membrane and activation is facilitated by a calcium-ion dependent conformational change in its C2 domain. In addition, phosphorylation of serine residues in PLA2G4A by protein kinases may be another regulatory mechanism for promoting the release of arachidonic acid. The knockout mouse studies of this enzyme indicate that the enzyme may play a major role in inflammatory diseases. Genetic ablation or reduction of PLA2G4A protected human amyloid precursor protein (APP) related pathogenesis from a mouse model. Mouse model studies of brain and lung cancer indicates that PLA2G4A may play a key regulatory role in angiogenesis of these tumors.

Recombinant protein corresponding to Met1-Ala749 from human PLA2G4A fused with 6-His-tag at C-terminal expressed in Sf21 cells. Accession Number: NP_077734

Molecular Weight:
~86kD

Biological Activity:
Measured by its ability to hydrolyze 1-Hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphocholine.

Specific Activity:
≥15pmol/min/µg

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Shelf Life
6 months

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close